References
- 1 Srebro SH, Roggli VL, Samsa GP. Malignant mesothelioma associated with low pulmonary tissue asbestos burdens: A light and scanning electron microscopic analysis of 18 cases. Mod Pathol. 1995, Aug; 8: 614–621.
- 2 Landrigan P. Collegium Ramazzini. Comments on the 2014 Helsinki Consensus Report on Asbestos. Ann Glob Health. 2016; 82: 217–220. DOI: 10.1016/j.aogh.2016.01.018
- 3 Baur X, Woitowitz H, Budnik L, et al. Asbestos, asbestosis, and cancer: The Helsinki criteria for diagnosis and attribution. Critical need for revision of the 2014 update. American Journal of Industrial Medicine. 2017; 60: 411–421. DOI: 10.1002/ajim.22709
- 4 Wolff H, Vehmas T, Oksa P, et al. Response by the organizers of the Helsinki criteria updates 2014: Criteria for asbestos-related diseases need periodic updates. Scand J Work Environ Health. 2016; 42: 95–96. DOI: 10.5271/sjweh.3536
- 5 Pavlisko EN, Liu B, Green C, et al. Malignant Diffuse Mesothelioma in Women: A Study of 354 Cases. The American Journal of Surgical Pathology. 2020; 44: 293–304. DOI: 10.1097/PAS.0000000000001418
-
6
Roggli
V,
Greenberg
M,
Pratt
P.
Pathology of asbestos-associated diseases . 1st ed. Boston, MA: Little, Brown & Co; 1992. DOI: 10.1007/0-387-21819-X_1 - 7 Roggli V. Asbestos content of lung tissue in asbestos associated diseases: A study of 110 cases. British Journal of Industrial Medicine. 1986; 43: 18–28. DOI: 10.1136/oem.43.1.18
- 8 Agency for Toxic Substances and Disease Registry (ATSDR). Toxicological Profile for Asbestos. 2001.
- 9 Goldberg M, Luce D. The health impact of nonoccupational exposure to asbestos: What do we know? Eur J Cancer Prev. 2012; 18: 489–503. DOI: 10.1097/CEJ.0b013e32832f9bee
- 10 U.S. Environmental Protection Agency. Title 40 — protection of environment, Chapter 1, Subchapter C. Air programs, Part 61. National emission standards for hazardous air pollutants: asbestos, beryllium, and mercury. 38 FR 8820–8850. 1973.
- 11 U.S. Environmental Protection Agency. National Emission Standards for Hazardous Air Pollutants (NESHAP): proposed standards for asbestos, beryllium, mercury. 1971.
- 12 Egilman D. Fiber Types, Asbestos Potency, and Environmental Causation: A Peer Review of Published Work and Legal and Regulatory Scientific Testimony. Int J Occup Environ Health. 2009; 15: 202–228. DOI: 10.1179/oeh.2009.15.2.202
-
13
Roggli
V. Electron
Microprobe Analysis of Ferruginous Bodies Obtained from Autopsy
Cases. 1995.
https://repository.library.brown.edu/studio/item/bdr:1095276/ . Accessed June 23, 2020. - 14 Albin M, Pooley F, Strömberg U, et al. Retention patterns of asbestos fibres in lung tissue among asbestos cement workers. Occup Environ Med. 1994; 51: 205–211. DOI: 10.1136/oem.51.3.205
-
15
Newman
L,
Gottschall
E.
Asbestosis . In: Albert R (ed.), Clinical Respiratory Medicine. Philadelphia, PA: Mosby, Inc.; 2008. DOI: 10.1016/B978-032304825-5.10065-0 -
16
Lajoie
P,
Dion
C,
Drouin
L, et al.
Asbestos Fibres in Indoor and Outdoor Air – The Situation in Quebec . In: Sub-Committee on Exposure Measurement (ed.), Institut national de santé publique du Québec (INSPQ), 2003.https://www.inspq.qc.ca/pdf/publications/342-AsbestosIndoorOutdoorAir.pdf . Accessed June 23, 2020. -
17
United States Geological
Survey.
Mineral Commodity Summaries 2020 . In: U.S. Department of the Interior BoM (ed.), 2020.https://pubs.usgs.gov/periodicals/mcs2020/mcs2020.pdf . Accessed June 23, 2020. -
18
Roggli
V.
Deposition in Boyle vs. A.W. Chesterton Company et al. in the Iowa District Court for Polk County . 2009; 130–132.https://repository.library.brown.edu/studio/item/bdr:1097892/ . Accessed June 23, 2020. - 19 Sayers R, Dreessen W. Asbestosis. Am J Public Health Nations Health. 1939; 29: 205–214. DOI: 10.2105/AJPH.29.3.205
- 20 Dodson R, Atkinson M, Levin J. Asbestos Fiber Length as Related to Potential Pathogenicity: A Critical Review. American Journal of Industrial Medicine. 2003; 44: 291–297. DOI: 10.1002/ajim.10263
- 21 Hume L, Rimstidt D. Letter: The biodurability of chrysotile asbestos. American Mineralogist. 1992; 77: 1125–1128.
- 22 Jaurand M, Gaudichet A, Halpern S, et al. In vitro biodegradation of chrysotile fibers by alveolar macrophages and mesothelial cells in culture: Comparison with a pH effect. British J Ind Medicine. 1984; 41: 389–395. DOI: 10.1136/oem.41.3.389
- 23 Churg A, Wright J. Persistence of natural mineral fibers in human lungs: An overview. Environ Health Perspect. 1994; 102: 229–233. DOI: 10.1289/ehp.94102s5229
- 24 Roggli VL, Sanders LL. Asbestos content of lung tissue and carcinoma of the lung: A clinicopathologic correlation and mineral fiber analysis of 234 cases. Ann Occup Hyg. 2000; 44: 109–117. DOI: 10.1016/S0003-4878(99)00067-8
- 25 Warnock M, Prescott B, Kuwahara T. Correlation of Asbestos Bodies and Fibers in Lungs of Subjects With and Without Asbestosis. Scan Electron Microsc. 1982; Part 2: 845–857.
- 26 Aust A, Cook P, Dodson R. Morphological And Chemical Mechanisms Of Elongated Mineral Particle Toxicities. Journal of Toxicology and Environmental Health, Part B. 2011; 14: 40–75. DOI: 10.1080/10937404.2011.556046
- 27 Smith A, Wright C. Chrysotile asbestos is the main cause of pleural mesothelioma. Am J Ind Med. 1996; 30: 252–266. DOI: 10.1002/(SICI)1097-0274(199609)30:3<;252::AID-AJIM2>3.0.CO;2-0
- 28 Churg A, Warnock M. Asbestos Fibers in the General Population. American Review of Respiratory Disease. 1980; 122: 669–678. DOI: 10.1164/arrd.1980.122.5.669
- 29 Anttila S, Karjalainen A, Taikina-aho O, et al. Lung cancer in the lower lobe is associated with pulmonary asbestos fiber count and fiber size. Environ Health Perspect. 1993; 101: 166–170. DOI: 10.1289/ehp.93101166
- 30 Gylseth B, Randi B. Topographic and Size Distribution of Asbestos Bodies in Exposed Human Lungs. Scandinavian Journal of Work, Environment & Health. 1981; 7: 190–195. DOI: 10.5271/sjweh.3111
- 31 Finnish Institute of Occupational Health. Asbestos, Asbestosis and Cancer: Helsinki Criteria for Diagnosis and Attribution 2014. 2014.
-
32
U.S. Environmental Protection
Agency. AHERA Training Workshop for NESHAP
Inspectors – Student Manual. In: Office of Air
Quality and Standards (ed.), Washington, DC
20460. 1990.
https://nepis.epa.gov/Exe/ZyPDF.cgi/91024QIF.PDF?Dockey=91024QIF.PDF . Accessed June 23, 2020. -
33
Upton
A,
Barrett
J,
Becklake
M, et al.
Asbestos in Public and Commercial Buildings: A Literature Review and Synthesis of Current Knowledge . In: Health Effects Institute (HEI) (ed.), 1991.https://www.healtheffects.org/system/files/SR_1991_Ch1-5_0.pdf . Accessed June 23, 2020. -
34
Rigler
MW. Expert Report:
Regarding Alan R. Lohman Lung Tissue Analysis For
Asbestos Burden Performed by Victor Roggli,
MD. MAS Laboratory, 2010.
https://repository.library.brown.edu/studio/item/bdr:1097460/ . Accessed June 23, 2020. - 35 Pooley F, Clark N. Fiber dimensions and aspect ratio of crocidolite, chrysotile and amosite particles detected in lung tissue specimens. Annals New York Academy of Sciences. 1979; 330: 711–716. DOI: 10.1111/j.1749-6632.1979.tb18775.x
-
36
Dodson
R,
Hammar
S.
Asbestos: Risk Assessment, Epidemiology, and Health Effects . Boca Raton, FL: CRC Press – Taylor & Francis Group; 2011. - 37 Roggli V, Gibbs A, Attanoos R, et al. Pathology of asbestosis- An update of the diagnostic criteria: Report of the asbestosis committee of the college of american pathologists and pulmonary pathology society. Arch Pathol Lab Med. 2010; 134: 462–480. DOI: 10.5858/134.3.462
- 38 Langer A, Nolan R, Addison J. Distinguishing between amphibole asbestos fibers and elongate leavage fragments of the non-asbestos analogues. Mechanisms in Fibre Carcinogenesis. 1991. DOI: 10.1007/978-1-4684-1363-2_22
-
39
Egilman
D.
Health Effects of Censored Elongated Mineral Particles: A Critical Review . In: Brisson M (ed.), Detection Limits in Air Quality and Environmental Measurements. West Conshohocken, PA: ASTM International. 2019; 192–239. DOI: 10.1520/STP161820180080 - 40 Sullivan M, Corn C, Dodson R. Comparative Efficiency of Nuclepore Filters of Various Pore Sizes as Used in Digestion Studies of Tissue. Environmental Research. 1987; 43: 97–103. DOI: 10.1016/S0013-9351(87)80061-0
- 41 Wylie A. Discriminating Amphibole Cleavage Fragments from Asbestos: Rationaled and Methodology. Exposure Assessment and Control Asbestos/Other Fibrous Material. 1988.
- 42 International Organization for Standardization. ISO 14966: Ambient air — Determination of numerical concentration of inorganic fibrous particles — Scanning electron microscopy method. 2019.
-
43
Chesson
J,
Leczynski
B,
Berner
T, et al.
Guidelines for conducting the AHERA (Asbestos Hazard Emergency Response Act) TEM (Transmission Electron Microscopy) clearance test to determine completion of an asbestos abatement project . Final report. Report no. PB-90-171778/XAB United States NTIS, PC A03/MF A01 GRA English, 1989.; Washington, DC, USA: Chesson Consulting. -
44
Roggli
V. Deposition in
Stepanek vs. Brenntag North America et al. in the Circuit Court of Cook
County, Illinois. 2020;
48–49.
https://repository.library.brown.edu/studio/item/bdr:1095278/ . Accessed June 23, 2020. - 45 Virta RL. The Phase Relationship of Talc and Amphiboles in a Fibrous Talc Sample. 1985.
- 46 Roggli V, Carney J, Sporn T, et al. Response to letter regarding “Talc and mesothelioma: Mineral fiber analysis of 65 cases with clinicopathological correlation.” Ultrastructural Pathology. 2020. DOI: 10.1080/01913123.2020.1737286
- 47 Gordon R. Cosmetic Talcum Powder as a Causative Factor in the Development of Diseases of the Pleura. Diseases of Pleura. 2019. DOI: 10.5772/intechopen.88194
- 48 Langer A, Nolan R. Chrysotile: Its Occurrence And Properties As Variables Controlling Biological Effects. British Occupational Hygiene Society. 1993; 33: 427–451.
- 49 Pooley F. Electron microscope characteristics of inhaled chrysotile asbestos fibre. Brit J industr Med. 1972; 29: 146–153. DOI: 10.1136/oem.29.2.146
-
50
Roggli
V. Deposition in
Ropp vs. American Honda Motor Company et al. in the Circuit Court of
Caroline County, Maryland. 2015;
62–63.
https://repository.library.brown.edu/studio/item/bdr:1105308/ . Accessed June 23, 2020. - 51 Feder I, Tischoff I, Theile A, et al. The asbestos fibre burden in human lungs: New insights into the chrysotile debate. Eur Respir J. 2017; 49: 1602534. DOI: 10.1183/13993003.02534-2016
-
52
Roggli
V. Deposition in
Ropp vs. American Honda Motor Company et al. in the Circuit Court of
Caroline County, Maryland. 2015;
76–78.
https://repository.library.brown.edu/studio/item/bdr:1105308/ . Accessed June 23, 2020. -
53
Oury
T,
Roggli
V,
Sporn
T.
Pathology of asbestos-associated diseases . Third Edition ed. New York, NY: Springer; 2014. DOI: 10.1007/978-3-642-41193-9 - 54 Gylseth B, Churg A, Davis J, et al. Analysis of asbestos fibers and asbestos bodies in tissue samples from human lung. An international interlaboratory trial. Scand J Work Environ Health. 1985; 11: 107–110. DOI: 10.5271/sjweh.2246
- 55 Case W, Abraham J, Meeker G, et al. Applying Definitions of “Asbestos” to Environmental and “Low-Dose” Exposure Levels and Health Effects, Particularly Malignant Mesothelioma. Journal of Toxicology and Environmental Health. 2011; Part B: 3–39. DOI: 10.1080/10937404.2011.556045
- 56 Churg A. The Distribution of Amosite Asbestos in the Periphery of the Normal Human Lung. British Journal of Industrial Medicine. 1990; 47: 677–681. DOI: 10.1136/oem.47.10.677
- 57 Roggli V, Carney J, Sporn T, et al. Talc and mesothelioma: Mineral fiber analysis of 65 cases with clinicopathological correlation. Ultrastructural Pathology. 2020; 44: 211–218. DOI: 10.1080/01913123.2020.1737286
- 58 Tran T, Steffen J, Clancy K, et al. Talc, Asbestos, and Epidemiology: Corporate Influence and Scientific Incognizance. Epidemiology. 2019; 30: 783–788. DOI: 10.1097/EDE.0000000000001091
-
59
National Toxicology
Program.
Draft Report on Carcinogens: Background Document for Talc – Asbestiform and Non-Asbestiform . Meeting of the NTP Board of Scientific Counselors – Report on Carcinogens Subcommittee. 2000.https://repository.library.brown.edu/studio/item/bdr:841468/ . Accessed June 23, 2020. - 60 Steffen JE, Tran T, Yimam M, et al. Serous Ovarian Cancer Caused by Exposure to Asbestos and Fibrous Talc in Cosmetic Talc Powders—A Case Series. Journal of Occupational and Environmental Medicine. 2020; 62: e65–e77. DOI: 10.1097/JOM.0000000000001800
-
61
Roggli
V. Deposition in
Stepanek vs. Brenntag North America et al. in the Circuit Court of Cook
County, Illinois. 2020;
93–94.
https://repository.library.brown.edu/studio/item/bdr:1095278/ . Accessed June 23, 2020. -
62
Roggli
VL. Deposition in
DiBenedetto vs. Noble Drilling Company et. al. in the Civil District Court
of the Parish of New Orleans page 268–271.
2009.
https://repository.library.brown.edu/studio/item/bdr:1095279/ . Accessed June 23, 2020. - 63 McEwen G. Letter to Dr. C.W. Jameson, NTP RE: Call for Public Comments on 21 Substances. Mixtures and Exposure Circumstances Proposed for Listing in the Report on Carcinogens, Twelfth Edition (69 Federal Register 28940): Cosmetic Talc. 2004.
- 64 Tossavainen A. Asbestos, asbestosis, and cancer: The Helsinki criteria for diagnosis and attribution. Scand J Work Environ Health. 1997; 23: 311–316. DOI: 10.5271/sjweh.226
- 65 Roggli V, Vollmer R, Butner K, et al. Tremolite and Mesothelioma. Ann Occup Hyg. 2002; 46: 447–453.
-
66
Ashton
W. Memo to Leebaw,
J. Re: Johnson’s Baby Powder Use, JNJ 000312709.
1991.
https://repository.library.brown.edu/studio/item/bdr:841456/ . Accessed June 23, 2020. - 67 Nam K, Gracey DR. Pulmonary talcosis from cosmetic talcum powder. JAMA. 1972; 221: 492–493. DOI: 10.1001/jama.1972.03200180034009
-
68
Roggli
V. Deposition in
Stepanek vs. Brenntag North America et al. in the Circuit Court of Cook
County, Illinois. 2020; 88.
https://repository.library.brown.edu/studio/item/bdr:1095278/ . Accessed June 23, 2020.
